Brief: Sprint Bioscience Q4 Operating Result Swings To Loss Of SEK 7.2 Million
Feb 7 (Reuters) - SPRINT BIOSCIENCE AB SPRINT.ST :
* Q4 REVENUE SEK 5.4 MILLION VERSUS SEK 13.0 MILLION YEAR
AGO
* Q4 OPERATING LOSS SEK 7.2 MILLION VERSUS PROFIT SEK 2.7
MILLION YEAR AGO
Source text for Eikon: ID:nWkr8c7XcR
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln